In the Original Investigation entitled “Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia: A Randomized Clinical Trial,” published in the May 21, 2014, issue of JAMA (2014;311:1978-1986. doi: 10.1001/jama.2014.4310), the name of a medication was misstated. In the Discussion section, a sentence in the second paragraph should have read, “The modest dose of haloperidol decanoate used here, approximately 75 mg intramuscularly per month, is lower than the equivalent oral dosage used in a trial that found an advantage of oral risperidone over oral haloperidol.9” Haloperidol decanoate cannot be administered orally. This article was corrected online.
Incorrect Medication. JAMA. 2014;312(14):1473. doi:10.1001/jama.2014.8826